Search

everythinglearnresearchcommunity

for

Search:↓

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Erlotinib can cause acne-like skin issues, needing early treatment and possible dosage adjustments.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

Enhanced stem cells from the placenta can reduce fat buildup in eye tissue for Graves' disease.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Sebaceous glands are often preserved and PPARy expression is constant in some cases of Central Centrifugal Cicatricial Alopecia.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Aggressive SLE treatment helped hair regrowth and improved oral plaque, but scalp lesions stayed.

Kerascalp hair serum was found to be safe and effective in improving hair growth and strength in people with mild to moderate hair loss.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

A circulating inhibitor caused insulin resistance, but clomiphene improved symptoms.

The cat's skin condition was resistant to treatment and did not improve.

The new patch for treating mouth sores releases medicine slowly, sticks well, and helps healing without the side effects of current creams.

New molecules can prevent cell death in hair follicles.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Pexidartinib often causes liver issues and fatigue, especially in women.

MK-5108 is safe and shows potential against tumors, especially alone.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a viable alternative.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Inhibiting ALOX12 can help hair cuticle maturation by increasing S100A3 citrullination.